These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

982 related articles for article (PubMed ID: 33789819)

  • 1. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    J Clin Epidemiol; 2021 Jun; 134():178-189. PubMed ID: 33789819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    Int J Surg; 2021 Apr; 88():105906. PubMed ID: 33789826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    Rev Esp Cardiol (Engl Ed); 2021 Sep; 74(9):790-799. PubMed ID: 34446261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas].
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    Rev Panam Salud Publica; 2022; 46():e112. PubMed ID: 36601438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Moher D
    J Clin Epidemiol; 2021 Jun; 134():103-112. PubMed ID: 33577987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
    McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
    JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Aiyegbusi OL; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    Health Qual Life Outcomes; 2024 Jul; 22(1):48. PubMed ID: 38978063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Aiyegbusi OL; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    J Patient Rep Outcomes; 2024 Jul; 8(1):64. PubMed ID: 38977535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.
    Elsman EBM; Mokkink LB; Terwee CB; Beaton D; Gagnier JJ; Tricco AC; Baba A; Butcher NJ; Smith M; Hofstetter C; Aiyegbusi OL; Berardi A; Farmer J; Haywood KL; Krause KR; Markham S; Mayo-Wilson E; Mehdipour A; Ricketts J; Szatmari P; Touma Z; Moher D; Offringa M
    Qual Life Res; 2024 Aug; 33(8):2029-2046. PubMed ID: 38980635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRISMA 2020 statement: What's new and the importance of reporting guidelines.
    Sohrabi C; Franchi T; Mathew G; Kerwan A; Nicola M; Griffin M; Agha M; Agha R
    Int J Surg; 2021 Apr; 88():105918. PubMed ID: 33789825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review.
    Page MJ; Moher D
    Syst Rev; 2017 Dec; 6(1):263. PubMed ID: 29258593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferred reporting items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension.
    O'Dea RE; Lagisz M; Jennions MD; Koricheva J; Noble DWA; Parker TH; Gurevitch J; Page MJ; Stewart G; Moher D; Nakagawa S
    Biol Rev Camb Philos Soc; 2021 Oct; 96(5):1695-1722. PubMed ID: 33960637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of reporting guidance for systematic reviews and meta-analyses generated a comprehensive item bank for future reporting guidelines.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann T; Mulrow CD; Shamseer L; Moher D
    J Clin Epidemiol; 2020 Feb; 118():60-68. PubMed ID: 31740319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
    Hutton B; Salanti G; Caldwell DM; Chaimani A; Schmid CH; Cameron C; Ioannidis JP; Straus S; Thorlund K; Jansen JP; Mulrow C; Catalá-López F; Gøtzsche PC; Dickersin K; Boutron I; Altman DG; Moher D
    Ann Intern Med; 2015 Jun; 162(11):777-84. PubMed ID: 26030634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
    Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
    J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    BMJ; 2021 Mar; 372():n71. PubMed ID: 33782057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    BMJ; 2009 Jul; 339():b2700. PubMed ID: 19622552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    PLoS Med; 2009 Jul; 6(7):e1000100. PubMed ID: 19621070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.